Despite the growing investigational experience with TM6SF2 and PNPLA3 polymorphisms in NAFLD, their role in the spectrum of liver disease by the hepatitis C virus is not yet fully defined. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.